We awarded the 2025 Future Insight Prize – a 250.000 € research grant – to Prof. Magdalena Götz, Munich, Germany today. Darmstadt, Germany — Merck KGaA, Darmstadt, Germany, a leading science and technology company, today awarded the 2025 Future Insight Prize to Prof. Magdalena Götz, representing the Helmholtz Center Munich. The award – a € 250,000 research […]
Company empowers ADME, hepatobiology, and toxicity research toward the goal of reducing the risk of adverse drug effects BALTIMORE — BioIVT, a global research partner and biospecimen solutions provider for drug and diagnostic development, today announced the opening of its Hepatocyte Grants Program and that it is actively reviewing research proposals. As a leader in […]
BILLERICA, Mass. — Quanterix Corporation (“Quanterix” or the “Company”) (NASDAQ: QTRX), a company fueling scientific discovery through ultra-sensitive biomarker detection, today announced that it has completed its previously announced acquisition of Akoya Biosciences, Inc., establishing a scaled leader in the early detection of disease for the neurology, oncology and immunology markets. Under the terms of […]
Researchers aim to discover dominant subtypes of plasmablasts initiating from the MMR vaccine in order to develop neutralizing antibody candidate therapies SEATTLE, Wash. — The Vanderbilt University Medical Center and Parse Biosciences today announced a strategic collaboration to generate a single cell atlas focused on understanding the diversity of plasmablasts – early immune cell clonotypes critical […]
Hamburg — This year, the Hamburg based life sicences company Eppendorf SE is awarding its prestigious research prize for the 30th time. The independent jury chaired by Prof. Laura Machesky, Cambridge, UK, selected Dr. Varun Venkataramani, Heidelberg University Hospital, Germany as the winner of the Eppendorf Award for Young European Investigators 2025. Varun Venkataramani receives the […]
EQT Healthcare Growth to acquire Europa Biosite, a distributor of over ten million high-quality life science reagents to academic and biopharma researchers across Europe and North America, from Adelis Equity EQT will support Europa Biosite’s next phase of growth through commercial excellence initiatives, digital upgrades, expanded product access, and continued M&A, with the company set […]
The new suite extends GMP bioconjugate production for intermediates and active pharmaceutical ingredients from early clinical phase through to late clinical phases and commercial supply. Staad – Biosynth, a leading developer and supplier of critical raw materials and services for life sciences and diagnostics, is pleased to announce the opening of its expanded GMP bioconjugation […]
The life science group Sartorius has successfully closed the acquisition of MatTek Corp, including Visikol Inc, from the Swedish BICO Group AB, as announced in April. The acquisition was completed on July 1, 2025, following the receipt of the required regulatory approval and the fulfillment of other customary closing conditions. With the integration of the […]
Ann Arbor, MI — There is a growing demand from medical research institutions for high resolution, compact imaging tools to better study disease progression in areas such as cancer, cardiovascular and neurodegenerative diseases and to develop novel treatments including radiotherapies. The first systems from MH3D, US-based innovator in compact pre-clinical single photon emission computed tomography […]
ICO has as of today completed the divestment of MatTek and Visikol to Sartorius, for USD 80m on a cash and debt-free basis, after customary regulatory approval has been obtained. Following transaction costs, net debt and working capital adjustments net proceeds are estimated to amount to USD 77.2m. The divestment follows the Group’s updated strategy […]
Pay Invoice
Latest Blogs
-
Laboratory Tool Companies’ Dividends Show Stability
September 29, 2026 10:14 am
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
